Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treat-ment strategyOACSCD
Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treat-ment strategy
Yang Li;Dan-Yun Ruan;Chang-Chang Jia;Hui Zhao;Guo-Ying Wang;Yang Yang;Nan Jiang
Department of Hepatic Surgery and Liver Trans-plantation Center of the Third Affiliated Hospital, Organ Transplantation Institute of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, ChinaDepartment of Medical Oncology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, ChinaDepartment of Biotherapy, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, ChinaDepartment of Hepatic Surgery and Liver Trans-plantation Center of the Third Affiliated Hospital, Organ Transplantation Institute of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, ChinaDepartment of Hepatic Surgery and Liver Trans-plantation Center of the Third Affiliated Hospital, Organ Transplantation Institute of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, ChinaDepartment of Hepatic Surgery and Liver Trans-plantation Center of the Third Affiliated Hospital, Organ Transplantation Institute of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, ChinaDepartment of Hepatic Surgery and Liver Trans-plantation Center of the Third Affiliated Hospital, Organ Transplantation Institute of Sun Yat-Sen University, Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, China
hepatocellular carcinomasurgical resectionliver transplantationnomogramrecurrence-free survival
hepatocellular carcinomasurgical resectionliver transplantationnomogramrecurrence-free survival
《国际肝胆胰疾病杂志(英文版)》 2017 (5)
癌基因PTOV1增强肝癌干细胞样表型的分子机制
480-486,7
This study was supported by grants from the National Natural Science Foundation of China (81572368), Guangdong Natu-ral Science Foundation (2016A030313278), Science and Technology Planning Project of Guangdong Province, China (2014A020212084) and National Natural Science Youth Foundation of China (81600505).
评论